Cécile Rouleau

1.2k total citations
26 papers, 732 citations indexed

About

Cécile Rouleau is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cécile Rouleau has authored 26 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Cécile Rouleau's work include Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer therapeutics and mechanisms (5 papers). Cécile Rouleau is often cited by papers focused on Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer therapeutics and mechanisms (5 papers). Cécile Rouleau collaborates with scholars based in United States, Japan and France. Cécile Rouleau's co-authors include Beverly A. Teicher, Rebecca G. Bagley, William Weber, Leslie Kurtzberg, Laurie Feldman, Shiro Kataoka, Nakayuki Honma, Isao Ishida, Srinivas Shankara and Paula Boutin and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Cécile Rouleau

25 papers receiving 707 citations

Peers

Cécile Rouleau

ONCOL

IMMUN

PRM

John M. Garland United Kingdom

Xavier Canron France

Jane Lane United Kingdom

Elínborg Ostermann Austria

Erin M. Conn United States

Ylva Paulsson Sweden

Carolina Zandueta Spain

Andreas Enns Germany

Delphine Ciais France

F. Müller-Pillasch Germany

John M. Garland United Kingdom

Cécile Rouleau

528 ×1.2

171 ×0.7

ONCOL

144 ×1.1

125 ×1.3

IMMUN

93 ×1.0

PRM

Citations per year, relative to Cécile Rouleau Cécile Rouleau (= 1×) peers John M. Garland

Countries citing papers authored by Cécile Rouleau

Since Specialization

Citations

This map shows the geographic impact of Cécile Rouleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Rouleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Rouleau more than expected).

Fields of papers citing papers by Cécile Rouleau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Rouleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Rouleau. The network helps show where Cécile Rouleau may publish in the future.

Co-authorship network of co-authors of Cécile Rouleau

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Rouleau. A scholar is included among the top collaborators of Cécile Rouleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Rouleau. Cécile Rouleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rouleau, Cécile, Justin H. Hwang, Tao Jiang, et al.. (2016). Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. Journal of Virology. 90(16). 7032–7045. 13 indexed citations

Rouleau, Cécile, et al.. (2016). A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. Journal of Virology. 91(2). 3 indexed citations

Rouleau, Cécile, Diego A. Gianolio, Robert Smale, et al.. (2015). Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies. Molecular Cancer Therapeutics. 14(9). 2081–2089. 34 indexed citations

Gianolio, Diego A., Cécile Rouleau, William E. Bauta, et al.. (2012). Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates. Cancer Chemotherapy and Pharmacology. 70(3). 439–449. 28 indexed citations

Bagley, Rebecca G., Cécile Rouleau, William Weber, et al.. (2011). Tumor endothelial marker 7 (TEM-7): A novel target for antiangiogenic therapy. Microvascular Research. 82(3). 253–262. 22 indexed citations

Bagley, Rebecca G., Leslie Kurtzberg, Cécile Rouleau, Min Yao, & Beverly A. Teicher. (2011). Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells. Cancer Chemotherapy and Pharmacology. 68(6). 1537–1546. 30 indexed citations

Teicher, Beverly A., et al.. (2011). Characteristics of Human Ewing/PNET Sarcoma Models. Annals of Saudi Medicine. 31(2). 174–182. 2 indexed citations

Rouleau, Cécile, et al.. (2011). Endosialin expression in side populations in human sarcoma cell lines. Oncology Letters. 3(2). 325–329. 16 indexed citations

Mitsiades, Constantine S., Cécile Rouleau, Cinara Echart, et al.. (2009). Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias. Clinical Cancer Research. 15(4). 1210–1221. 46 indexed citations

10.

Kurtzberg, Leslie, Stephanie Roth, Rebecca G. Bagley, et al.. (2009). Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents. Cancer Chemotherapy and Pharmacology. 64(5). 1029–1038. 4 indexed citations

11.

Rouleau, Cécile, Robert Smale, Diego A. Gianolio, et al.. (2009). Abstract C80: Characterizing models for personalized medicine: Endosialin in sarcoma from cultured cells to mice to humans. Molecular Cancer Therapeutics. 8(12_Supplement). C80–C80. 1 indexed citations

12.

Yao, Min, Cécile Rouleau, Rebecca G. Bagley, et al.. (2009). Abstract C217: Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment. Molecular Cancer Therapeutics. 8(12_Supplement). C217–C217. 1 indexed citations

13.

Rouleau, Cécile, William Weber, Robert Smale, et al.. (2008). Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma. Clinical Cancer Research. 14(22). 7223–7236. 86 indexed citations

14.

Bagley, Rebecca G., Cécile Rouleau, Thia St Martin, et al.. (2008). Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Molecular Cancer Therapeutics. 7(8). 2536–2546. 42 indexed citations

15.

Bagley, Rebecca G., Nakayuki Honma, William Weber, et al.. (2008). Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvascular Research. 76(3). 180–188. 78 indexed citations

16.

Kurtzberg, Leslie, Traci E. Battle, Cécile Rouleau, et al.. (2008). Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics. 7(10). 3212–3222. 30 indexed citations

17.

Bagley, Rebecca G., Cécile Rouleau, Sharon D. Morgenbesser, et al.. (2006). Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvascular Research. 71(3). 163–174. 30 indexed citations

18.

Bagley, Rebecca G., William Weber, Cécile Rouleau, & Beverly A. Teicher. (2005). Pericytes and Endothelial Precursor Cells: Cellular Interactions and Contributions to Malignancy. Cancer Research. 65(21). 9741–9750. 81 indexed citations

19.

Rouleau, Cécile, et al.. (2004). A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl. Experimental Hematology. 32(2). 140–148. 8 indexed citations

20.

Feldman, Laurie & Cécile Rouleau. (2002). Troponin I Inhibits Capillary Endothelial Cell Proliferation by Interaction with the Cell's bFGF Receptor. Microvascular Research. 63(1). 41–49. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact